Cargando…
Chimeric Antigen Receptor T-Cell Therapy: A Beacon of Hope in the Fight Against Cancer
Despite significant advancements, relapses, and persistent malignancies are still a major challenge faced by the oncologists. Immunotherapy has shown remarkable potential in induction of sustained remission in refractory malignancies. Chimeric antigen receptor T-cell (CAR-T) therapy is a newer treat...
Autores principales: | Tariq, Syed Maaz, Haider, Syed Ali, Hasan, Mohammad, Tahir, Amber, Khan, Maria, Rehan, Arisha, Kamal, Anum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314790/ https://www.ncbi.nlm.nih.gov/pubmed/30613448 http://dx.doi.org/10.7759/cureus.3486 |
Ejemplares similares
-
Is Chimeric Antigen Receptor T-cell Therapy the Future of Autoimmunity Management?
por: Tahir, Amber
Publicado: (2018) -
Ichthyosis Congenita, Harlequin Type: A Fatal Case Report
por: Tahir, Amber, et al.
Publicado: (2018) -
Pulmonary Langerhans Cell Histiocytosis Associated with Bronchogenic Carcinoma
por: Khaliq, Muhammad F, et al.
Publicado: (2020) -
Cardiovascular Risk Profile of Chimeric Antigen Receptor T-cell Therapy
por: Ahmed, Talha
Publicado: (2020) -
Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma
por: Padda, Jaskamal, et al.
Publicado: (2021)